These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10311107)

  • 1. Cost of hepatitis B prevention in hospital employees: pre-exposure immunization.
    Kirkman-Liff B; Dandoy S; Kallet G
    J Health Care Technol; 1985; 1(3):141-54. PubMed ID: 10311107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified financial cost-effectiveness analysis of programs for prevention of hepatitis B accidental inoculation among hospital personnel in Thailand.
    Chongsuvivatwong V
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):189-93. PubMed ID: 2532789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple exposure of hospital employees to hepatitis B. Five case studies.
    Dandoy S; Kirkman-Liff B; Krakowski F
    Arch Intern Med; 1984 Apr; 144(4):720-3. PubMed ID: 6712369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on immunization strategies for hepatitis B in different endemic areas of China].
    Wang L; Li H; Wang S; Gong J; Zeng X; Li R; Nong Y; Huang Y; Chen X; Huang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):104-6. PubMed ID: 11864465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis B carriers in a mental health in-patient facility: implications for employee screening and vaccination.
    Franson TR; Ksobiech LJ; Simonsen HW
    Psychiatr Hosp; 1986; 17(2):81-3. PubMed ID: 10278763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK; Hutton G; Das Dores Pascoal E
    Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Rein DB; Weinbaum CM
    Vaccine; 2008 Oct; 26(42):5331-3. PubMed ID: 18706957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B vaccination of blood donors--a cost-benefit analysis.
    Gesemann M; Gentner P; Scheiermann N
    Beitr Infusionsther Transfusionsmed; 1994; 32():110-2. PubMed ID: 9422105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B prevention in small rural hospitals.
    Dandoy S; Kirkman-Liff B
    West J Med; 1984 Nov; 141(5):627-30. PubMed ID: 6516332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against viral hepatitis B for public health personnel: the case of the National Fund of Social Security].
    Saadallah N; Jaoua N; Ben Hamida A; Najjar T; Zouari B
    Tunis Med; 2001 Dec; 79(12):676-80. PubMed ID: 11892442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B in a medical center.
    Hansen JP; Falconer JA; Hamilton JD; Herpok FJ
    J Occup Med; 1981 May; 23(5):338-42. PubMed ID: 7241246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors.
    Daw MA; Siala IM; Warfalli MM; Muftah MI
    Saudi Med J; 2000 Dec; 21(12):1157-60. PubMed ID: 11360090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B immunisation in northern Ireland: an epidemiological and economic analysis.
    McKee CM; Dinsmore WW
    Ir Med J; 1989 Jun; 82(2):83-7. PubMed ID: 2503462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.